BioPoly

BioPoly, a spin-off from Schwartz Biomedical, is pioneering a novel class of orthopedic implants with its patented BioPoly material, which mimics natural cartilage function. The company has commercial products for the toe and radial head, an FDA-approved knee implant in clinical study, and is focused on expanding its pipeline for joint preservation. Founded and led by a team of seasoned experts in Fort Wayne, Indiana, BioPoly aims to bridge the gap between biological treatments and total joint arthroplasty.

Proprietary composite biomaterial combining hyaluronic acid for lubrication and ultra-high molecular weight polyethylene for strength, creating a self-lubricating, durable synthetic cartilage designed for partial joint resurfacing.

Competes with other synthetic cartilage/partial resurfacing companies (e.g., Cartiva, Moximed) and biological repair firms. Differentiation lies in its proprietary self-lubricating BioPoly material, which is designed to be durable and articulate safely against natural cartilage.